Acute Leukemias - Republican Scientific Medical Library
Acute Leukemias - Republican Scientific Medical Library
Acute Leukemias - Republican Scientific Medical Library
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
200 Chapter 15 · Burkitt’s <strong>Acute</strong> Lymphoblastic Leukemia (L 3ALL) in Adults<br />
in HIV-positive Burkitt lymphomas and leukemias [53,<br />
54]. The combination of HAART and intensive chemotherapy<br />
was feasible and resulted in long-term survivors<br />
in both series, which suggests that HAART should<br />
be combined with chemotherapy in L 3ALL patients.<br />
However those patients had generally received “classical”<br />
ALL protocols, and it is difficult to determine if underlying<br />
HIV infection worsened prognosis.<br />
The impact of intensive protocols now applied to<br />
non-HIV related cases of disseminated BL and L 3ALL<br />
on the prognosis of HIV-related cases is also difficult<br />
to determine. Such protocols should probably be applied<br />
whenever possible, i.e., in patients without advanced<br />
AIDS symptoms and without very low CD4<br />
counts.<br />
15.8 Conclusion<br />
L3ALL is a rare type of adult ALL, probably difficult to<br />
distinguish from disseminated BL involving the bone<br />
marrow. This tumor is highly proliferative, and tends<br />
to involve the CNS at diagnosis or rapidly during the<br />
disease course. It shows rapid chemosensitivity, initially<br />
leading to the risk of severe acute tumor lysis syndrome.<br />
Principles of its treatment, by comparison to the other<br />
types of ALL, include (i) a low-dose chemotherapy “prephase”<br />
to prevent acute tumor lysis syndrome; (ii) multiagent<br />
chemotherapy using high-dose cyclophosphamide,<br />
an anthracycline, high-dose MTX, high-dose<br />
Ara C and probably VP16. A short and intensive treatment<br />
(6–8 months) without maintenance, is indicated;<br />
(iii) early, intensive CNS treatment, with multiple triple<br />
intrathecal injections, high-dose MTX and high-dose<br />
Ara C, and possibly cranial irradiation. Autologous or<br />
allogeneic stem cell transplantation do not appear to<br />
be useful in first CR.<br />
Using such approaches, recent results suggest that<br />
about two thirds of L 3ALL in adults can be cured, i.e.,<br />
more than in any other type of adult ALL.<br />
References<br />
1. Bennett JM, Catovsky D, Daniel MT, et al. (1976) Proposals for the<br />
classification of the acute leukaemias. French-American-British<br />
(FAB) co-operative group. Br J Haematol 33(4):451<br />
2. Bloomfield CD, Goldman AI, Alimena G, et al. (1986) Chromosomal<br />
abnormalities identify high-risk and low-risk patients with acute<br />
lymphoblastic leukemia. Blood 67(2):415<br />
3. Flandrin G, Brouet JC, Daniel MT, Preudhomme JL (1975) <strong>Acute</strong><br />
leukemia with Burkitt’s tumor cells: A study of six cases with special<br />
reference to lymphocyte surface markers. Blood 45:183<br />
4. Berger R, Bernheim A (1982) Cytogenetic studies on Burkitt’s lymphoma-leukemia.<br />
Cancer Genet Cytogenet 7(3):231<br />
5. Dalla-Favera R, Gregni M, Erikson J, et al. (1982) Human C-myc<br />
oncogene is located on the region of chromosome 8 that is translocated<br />
in Burkitt’s lymphoma cells. Proc Natl Acad Sci 79:7824<br />
6. Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) World Health<br />
Organization Classification of Tumours. Pathology and genetics.<br />
Tumours of hematopoietic and lymphoid tissues. IARC Press, Lyon,<br />
pp 181–184<br />
7. Vassal G, Leverger G, Schaison G, Castaigne S (1986) Leucémies<br />
aiguës lymphoblastiques á cellules de Burkitt. Aspects cliniques,<br />
thérapeutiques et évolutifs. Nouv Rev Fr Hematol 28(3):141<br />
8. Massey EW, Moore J, Schold SC, Jr (1981) Mental neuropathy from<br />
systemic cancer. Neurology 31(10):1277<br />
9. Hoelzer D, Ludwig WD, Thiel E, et al. (1996) Improved outcome in<br />
adult B-cell acute lymphoblastic leukemia. Blood 87(2):495<br />
10. Navid F, Mosijczuk AD, Head DR, et al. (1999) <strong>Acute</strong> lymphoblastic<br />
leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology<br />
associated with a B-precursor immunophenotype: The<br />
Pediatric Oncology Group experience. Leukemia 13(1):135<br />
11. Hammami A, Chan WC, Michels SD, Nassar VH (1991) Mature B-cell<br />
acute leukemia: A clinical, morphological, immunological, and<br />
cytogenetic study of nine cases. Hematol Pathol 5(3):109<br />
12. Sullivan MP, Pullen DJ, Crist WM, et al. (1990) Clinical and biological<br />
heterogeneity of childhood B cell acute lymphocytic leukemia:<br />
Implications for clinical trials. Leukemia 4(1):6<br />
13. Lee EJ, Petroni GR, Schiffer CA, Freter CE, Johnson JL, Barcos M,<br />
Frizzera G, Bloomfield CD, Peterson BA (2001) Brief-duration<br />
high-intensity chemotherapy for patients with small noncleaved-cell<br />
lymphoma or FAB L3 acute lymphocytic leukemia: Results<br />
of cancer and leukemia group B study 9251. J Clin Oncol<br />
19:4014–4022<br />
14. Rizzieri DA, Johnson JL, Niedzwiecki D, Lee EJ, Vardiman JW,<br />
Powell BL, Barcos M, Bloomfield CD, Schiffer CA, Peterson BA,<br />
et al. (2004) Intensive chemotherapy with and without cranial radiation<br />
for Burkitt leukemia and lymphoma: Final results of Cancer<br />
and Leukemia Group B Study 9251.Cancer 100(7): 1438–1448<br />
15. Thomas DA, Cortes J, O‘Brien S, Pierce S, Faderl S, Albitar M, Hagemeister<br />
FB, Cabanillas FF, Murphy S, Keating MJ, et al. (1999) Hyper-CVAD<br />
program in Burkitt’s-type adult acute lymphoblastic<br />
leukemia. J Clin Oncol. 17:2461–2470<br />
16. Garcia JL, Hernandez JM, Gutierrez NC, Flores T, Gonzalez D,<br />
Calasanz MJ, Martinez-Climent JA, Piris MA, Lopez-Capitan C, Gonzalez<br />
MB, et al. (2003) Abnormalities on 1q and 7q are associated<br />
with poor outcome in sporadic Burkitt’s lymphoma. A cytogenetic<br />
and comparative genomic hybridization study. Leukemia 17:<br />
2016–2024<br />
17. Bernasconi C, Brusamolino E, Pagnucco G, Bernasconi P, Orlandi E,<br />
Lazzarino M (1991) Burkitt’s lymphoma/leukemia: A clinicopathologic<br />
study on 24 adult patients. Leukemia 5(Suppl 1):90<br />
18. Fenaux P, Lai JL, Miaux O, Zandecki M, Jouet JP, Bauters F (1989)<br />
Burkitt cell acute leukaemia (L3 ALL) in adults: A report of 18 cases<br />
[see comments]. Br J Haematol 71(3):371